Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9474728
Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
granted -
US 9474730
Methods and compositions for use with K-ras mediated disorders
granted -
US 9476052
RNAi inhibition of alpha-ENaC expression
granted -
US 9476051
Antisense modulation of superoxide dismutase 1, soluble expression
granted -
US 9476037
Factor VII polypeptides that are modified and uses thereof
granted -
US 9475880
Anti-CD134 (OX40) antibodies and uses thereof
granted -
US 9475875
Anti-EGFRvIII antibodies and uses thereof
granted -
US 9475871
Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins
granted -
US 9476047
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
granted -
US 9475822
Substituted 2- amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors
granted -
US 9475862
Neutralizing GP41 antibodies and their use
granted -
US 9475839
Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling
granted -
US 9468208
Disease control with tick phospholipase A2
granted -
US 9469879
Lymphoma prognostic methods and kits
granted -
US 9469878
Methods of treating cancer comprising targeting NQO1
granted -
US 9469683
Lysosomal targeting peptides and uses thereof
granted -
US 9469664
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
granted -
US 9469637
Nitrogenated heterocyclic compound
granted -
US 9468684
Hydrogel implants with varying degrees of crosslinking
granted -
US 9468669
Methods to treat dysregulated blood glucose disorders
granted -
US 9468611
d-Methadone for the treatment of psychiatric symptoms
granted -
US 9468624
Small molecule antagonists of bacterial quorum-sensing receptors
granted -
PT 2481410
NITROCATECHOL DERIVATES AS COMT INHIBITORS ADMINISTERED WITH A SPECIFIC DOSAGE REGIME
granted -
US 9470689
N-cadherin: target for cancer diagnosis and therapy
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.